{
    "Rank": 653,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT03455023",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "ECCOPG-002"
                },
                "Organization": {
                    "OrgFullName": "Zhejiang Cancer Hospital",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Individualized Pharmaceutical-care for Inpatients With Cancer Pain",
                "OfficialTitle": "Impact of Individualized Pharmaceutical-care on Medication Adherence and Outcome of Cancer Pain in Opioid-tolerant Inpatients"
            },
            "StatusModule": {
                "StatusVerifiedDate": "January 2019",
                "OverallStatus": "Unknown status",
                "LastKnownStatus": "Recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "June 30, 2018",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "June 30, 2019",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "June 30, 2019",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "January 30, 2018",
                "StudyFirstSubmitQCDate": "February 27, 2018",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "March 6, 2018",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "January 13, 2019",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "January 15, 2019",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Ping Huang",
                    "ResponsiblePartyInvestigatorTitle": "Chief of Pharmacy",
                    "ResponsiblePartyInvestigatorAffiliation": "Zhejiang Cancer Hospital"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Zhejiang Cancer Hospital",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant inpatients",
                "DetailedDescription": "This study is a prospective multicenter randomized controlled study to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant inpatients."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Cancer Pain"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Cancer pain",
                        "Pharmaceutical care"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Not Applicable"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "Randomized",
                    "DesignInterventionModel": "Parallel Assignment",
                    "DesignPrimaryPurpose": "Supportive Care",
                    "DesignMaskingInfo": {
                        "DesignMasking": "None (Open Label)"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "500",
                    "EnrollmentType": "Anticipated"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "pharmaceutical care intervention group",
                            "ArmGroupType": "Experimental",
                            "ArmGroupDescription": "Patients will receive individualized pharmaceutical care in addition to usual medical care.",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Other: pharmaceutical care"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "control group",
                            "ArmGroupType": "No Intervention",
                            "ArmGroupDescription": "Patients will receive usual medical care."
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Other",
                            "InterventionName": "pharmaceutical care",
                            "InterventionDescription": "Patients receive pharmaceutical care including individualized evaluation and intervention of adherence, efficacy and safety in cancer pain treatment.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "pharmaceutical care intervention group"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Change in medication adherence",
                            "PrimaryOutcomeDescription": "The investigators will measure the change in medication adherence via Morisky Scale. Morisky Scale contains 4 questions, and the total score ranges from 0 to 4 with lower scores indicating higher adherence.",
                            "PrimaryOutcomeTimeFrame": "Change from baseline at 1 month after discharge"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Change in pain score",
                            "SecondaryOutcomeDescription": "Comparison of pain score of cancer pain patients with or without pharmaceutical care. Pain score will be assessed using numeric rating scale (NRS). An NRS allows a person to describe the intensity of his/her pain as a number usually ranging from 0 to 10, where \"0\" means \"no pain\" and \"10\" means pain as \"bad as it could be.\"",
                            "SecondaryOutcomeTimeFrame": "Change from baseline at 1 month after discharge"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Change in quality of life",
                            "SecondaryOutcomeDescription": "Comparison of quality of life of cancer pain patients with or without pharmaceutical care. Quality of life is assessed using EuroQol- 5 Dimension (EQ-5D). It is a questionnaire to measure quality of life. It contains 5 domains: Mobility; Self-care; Usual activity; Pain; Anxiety/depression. It also contains a visual analogue scale. Weights are used to score the responses to the 5 domains, with scores ranging from 0 to 1 (where a score of 1 represents a perfect state). For the visual analogue scale, participants draw a line from a box to the point on the thermometer-like scale corresponding to their health state, 0-100 (100 = Best health state)",
                            "SecondaryOutcomeTimeFrame": "Change from baseline at 1 month after discharge"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Change in patients' knowledge of cancer pain and analgesics",
                            "SecondaryOutcomeDescription": "Comparison of knowledge of cancer pain and analgesics for cancer pain patients with or without pharmaceutical care. Knowledge of pain treatment and analgesics will be assessed using investigator designed questionnaire. This questionnaire consists of 16 items assessing patients' knowledge about cancer pain, treatment of cancer pain and medications for cancer pain. The total score ranges from 0 to 16 with higher score indicating better knowledge.",
                            "SecondaryOutcomeTimeFrame": "Change from baseline at 1 month after discharge"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Incidence of adverse events [safety and tolerability]",
                            "SecondaryOutcomeDescription": "Adverse events will be assessed throughout the study according the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Event (CTCAE) Version 4.0. Number of subjects who experienced an adverse event in this study is presented.",
                            "SecondaryOutcomeTimeFrame": "Up to 1 month after discharge"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nPatients aged 18 years or older;\nHistologically confirmed solid tumor;\nDiagnosed chronic cancer pain;\nOpioid-tolerant patients;\nOverall survival is expected to be over 3 months;\nKarnofsky performance score\u226550;\nWilling and able to comply with the protocol\n\nExclusion Criteria:\n\nCurrent pregnancy or breastfeeding;\nPatients diagnosed with non-cancer pain;\nPatients treated with patient-controlled analgesia;\nPatients with pathological fracture, gastrointestinal obstruction, severe infection, non-opioid related intractable constipation;\nPatients with mental disorder;\nCreatinine clearance rate <15mL/min;\nALT or AST \u2265 10 fold of upper limit of normal value",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "18 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "CentralContactList": {
                    "CentralContact": [
                        {
                            "CentralContactName": "Ping Huang, Doctor",
                            "CentralContactRole": "Contact",
                            "CentralContactPhone": "+86-571-88122118",
                            "CentralContactEMail": "huangping1841@zjcc.org.cn"
                        }
                    ]
                },
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Ping Huang, Doctor",
                            "OverallOfficialAffiliation": "Zhejiang Cancer Hospital",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Zhejiang cancer hospital",
                            "LocationStatus": "Recruiting",
                            "LocationCity": "Hangzhou",
                            "LocationState": "Zhejiang",
                            "LocationZip": "310022",
                            "LocationCountry": "China",
                            "LocationContactList": {
                                "LocationContact": [
                                    {
                                        "LocationContactName": "Ping Huang, Doctor",
                                        "LocationContactRole": "Contact"
                                    }
                                ]
                            }
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "ReferenceList": {
                    "Reference": [
                        {
                            "ReferencePMID": "35092599",
                            "ReferenceType": "derived",
                            "ReferenceCitation": "Zheng X, Ding H, Xu S, Xie R, Liu Y, Zhai Q, Fang L, Tong Y, Sun J, Xin W, Wu N, Chen J, Shi W, Yang L, Li H, Shao J, Wang Y, Yu H, Zhang B, Du Q, Yang Y, Zhang X, Duan C, Zhao Q, Shi J, Huang J, Fan Q, Cheng H, Chen L, Kong S, Zhang H, Gong L, Zhang Y, Song Z, Yang Y, Zhou S, Huang C, Lin J, Wang C, Huang X, Wei Q, Sun Y, Huang P. Pharmacist-Led Management Improves Treatment Adherence and Quality of Life in Opioid-Tolerant Patients With Cancer Pain: A Randomized Controlled Trial. Pain Ther. 2022 Mar;11(1):241-252. doi: 10.1007/s40122-021-00342-0. Epub 2022 Jan 29."
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000072716",
                            "ConditionMeshTerm": "Cancer Pain"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000010146",
                            "ConditionAncestorTerm": "Pain"
                        },
                        {
                            "ConditionAncestorId": "D000009461",
                            "ConditionAncestorTerm": "Neurologic Manifestations"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M12756",
                            "ConditionBrowseLeafName": "Pain",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M1091",
                            "ConditionBrowseLeafName": "Cancer Pain",
                            "ConditionBrowseLeafAsFound": "Cancer Pain",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M12094",
                            "ConditionBrowseLeafName": "Neurologic Manifestations",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC23",
                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC10",
                            "ConditionBrowseBranchName": "Nervous System Diseases"
                        }
                    ]
                }
            },
            "InterventionBrowseModule": {
                "InterventionBrowseLeafList": {
                    "InterventionBrowseLeaf": [
                        {
                            "InterventionBrowseLeafId": "M3723",
                            "InterventionBrowseLeafName": "Analgesics, Opioid",
                            "InterventionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "InterventionBrowseBranchList": {
                    "InterventionBrowseBranch": [
                        {
                            "InterventionBrowseBranchAbbrev": "Analg",
                            "InterventionBrowseBranchName": "Analgesics"
                        },
                        {
                            "InterventionBrowseBranchAbbrev": "CNSDep",
                            "InterventionBrowseBranchName": "Central Nervous System Depressants"
                        },
                        {
                            "InterventionBrowseBranchAbbrev": "All",
                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                        }
                    ]
                }
            }
        }
    }
}